DJIA 17,156.85 24.88 0.15%
NASDAQ 4,562.19 9.43 0.21%
S&P 500 2,001.57 2.59 0.13%
market minute promo

Verastem, Inc. (NASDAQ: VSTM)

9.35 0.44 (4.94%)

REAL-TIME: Last trade at

Extended Hours: $9.35 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

VSTM $9.35 4.94%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.95
Previous Close $8.91
Daily Range $8.95 - $9.60
52-Week Range $7.10 - $16.60
Market Cap $241.6M
P/E Ratio -4.69
Dividend (Yield) $0.00 (0.0%)
Volume 150,662
Average Daily Volume 173,616
Current FY EPS -$2.10

Sector

Healthcare

Industry

Drugs

Verastem, Inc. (VSTM) Description

Verastem Inc is a biopharmaceutical company focused on discovering and developing proprietary small molecule drugs targeting cancer stem cells along with proprietary companion diagnostics. Website: http://www.verastem.com/

News & Commentary Rss Feed

Verastem Inc.'s Upcoming Catalysts

Verastem might have to compete with GlaxoSmithKine, but Eli Lilly won't be a problem since it's targeting patients that have already taken Lilly's drug.

Verastem (VSTM) Crumbles: Stock Falls by 6.1% - Tale of the Tape

Verastem (VSTM) in Focus: Stock Adds 14% in Session - Tale of the Tape

Why Verastem Inc Shares Took Off Today

Is this meaningful? Or just another movement?

Healthcare Stocks Mixed; Verastem Surges After Publishing Supportive Data for Its Anti-Cancer Therap

Healthcare Stocks Mixed; Verastem Surges After Publishing Supportive Data for Its Anti-Cancer Therapy

Sector Update: Healthcare

UPDATE: Deutsche Bank Initiates Coverage On Verastem On Multiple Positive Factors

Oversold Conditions For Verastem (VSTM)

Verastem: Cancer May Have Met Its Match

Verastem Becomes Oversold (VSTM)

See More VSTM News...